Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William L Isley

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
JAMA|January 6, 2005
High-dose statins in acute coronary syndromesWilliam L Isley
Evidence-Based Medicine|January 11, 2007
Pioglitazone did not reduce macrovascular complications and increased HF in type 2 diabetes with macrovascular diseaseWilliam L Isley
The New England Journal of Medicine|January 6, 2006
Ketoacidosis during a low-carbohydrate dietPankaj Shah, William L Isley
ACP Journal Club|January 6, 2007
Review: ACE inhibitors and angiotensin-receptor blockers reduce diabetes in hypertension and other CV risk factorsGunjan Y Gandhi, William L Isley
The American Journal of Cardiology|July 4, 2006
Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) TrialMichelle F Magee, William L Isley,
Archives of Internal Medicine|June 22, 2002
Massah and mechanismsWilliam S Harris, William L Isley
Mayo Clinic Proceedings|May 13, 2005
Getting there: statin plus ezetimibe for low-density lipoprotein cholesterol goalsDaniel L Hurley, William L Isley
ACP Journal Club|January 6, 2007
Ramipril did not reduce incident diabetes in patients with impaired glycemic controlGunjan Y Gandhi, William L Isley
Platelets|August 25, 2006
The effect of high dose simvastatin on, platelet size in patients with, type 2 diabetes mellitusWilliam L Isley, Youngsoon Park, William S Harris
Current Opinion in Lipidology|January 25, 2003
Cardiovascular disease and long-chain omega-3 fatty acidsWilliam S Harris, Yongsoon Park, William L Isley
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
JAMA|January 6, 2005
High-dose statins in acute coronary syndromesWilliam L Isley
Evidence-Based Medicine|January 11, 2007
Pioglitazone did not reduce macrovascular complications and increased HF in type 2 diabetes with macrovascular diseaseWilliam L Isley
The New England Journal of Medicine|January 6, 2006
Ketoacidosis during a low-carbohydrate dietPankaj Shah, William L Isley
ACP Journal Club|January 6, 2007
Review: ACE inhibitors and angiotensin-receptor blockers reduce diabetes in hypertension and other CV risk factorsGunjan Y Gandhi, William L Isley
The American Journal of Cardiology|July 4, 2006
Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) TrialMichelle F Magee, William L Isley,
Archives of Internal Medicine|June 22, 2002
Massah and mechanismsWilliam S Harris, William L Isley
Mayo Clinic Proceedings|May 13, 2005
Getting there: statin plus ezetimibe for low-density lipoprotein cholesterol goalsDaniel L Hurley, William L Isley
ACP Journal Club|January 6, 2007
Ramipril did not reduce incident diabetes in patients with impaired glycemic controlGunjan Y Gandhi, William L Isley
Platelets|August 25, 2006
The effect of high dose simvastatin on, platelet size in patients with, type 2 diabetes mellitusWilliam L Isley, Youngsoon Park, William S Harris
Current Opinion in Lipidology|January 25, 2003
Cardiovascular disease and long-chain omega-3 fatty acidsWilliam S Harris, Yongsoon Park, William L Isley
Pageof 4